<?xml version="1.0" encoding="UTF-8"?>
<p id="Par19">The pharmacokinetic studies demonstrate a profile that is similar to what has been observed with single agent ixazomib as well as ixazomib used in combination with lenalidomide and dexamethasone in previous studies (Fig. 
 <xref rid="Fig4" ref-type="fig">4</xref>).
</p>
